194 related articles for article (PubMed ID: 38502412)
1. Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma-A Systematic Review.
Devi P; Dwivedi R; Sankar R; Jain A; Gupta S; Gupta S
Head Neck Pathol; 2024 Mar; 18(1):21. PubMed ID: 38502412
[TBL] [Abstract][Full Text] [Related]
2. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
3. Analysis of H-ras Mutations and Immunohistochemistry in Recurrence Cases of High-Grade Oral Squamous Cell Carcinoma.
Hamidavi Asl A; Shirkhoda M; Saffar H; Allameh A
Head Neck Pathol; 2023 Jun; 17(2):347-354. PubMed ID: 36374444
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between dental implants and oral squamous cell carcinoma.
Afrashtehfar KI; Almomani MM; Momani M
Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
[TBL] [Abstract][Full Text] [Related]
5. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
6.
Mustansar T; Mirza T; Hussain M
Biotech Histochem; 2023 Nov; 98(6):382-390. PubMed ID: 37013448
[TBL] [Abstract][Full Text] [Related]
7. [Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review].
Kizhakkoottu S; Ramani P
Arkh Patol; 2024; 86(1):57-64. PubMed ID: 38319274
[TBL] [Abstract][Full Text] [Related]
8. Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma.
Lin LH; Chang KW; Cheng HW; Liu CJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373553
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.
Cohen Y; Goldenberg-Cohen N; Shalmon B; Shani T; Oren S; Amariglio N; Dratviman-Storobinsky O; Shnaiderman-Shapiro A; Yahalom R; Kaplan I; Hirshberg A
Oral Oncol; 2011 Oct; 47(10):946-50. PubMed ID: 21824802
[TBL] [Abstract][Full Text] [Related]
11. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
12. Studies on the Contribution of Cox-2 Expression in the Progression of Oral Squamous Cell Carcinoma and H-Ras Activation.
Moazeni-Roodi A; Allameh A; Harirchi I; Motiee-Langroudi M; Garajei A
Pathol Oncol Res; 2017 Apr; 23(2):355-360. PubMed ID: 27628320
[TBL] [Abstract][Full Text] [Related]
13. Ras oncogenes in oral cancer: the past 20 years.
Murugan AK; Munirajan AK; Tsuchida N
Oral Oncol; 2012 May; 48(5):383-92. PubMed ID: 22240207
[TBL] [Abstract][Full Text] [Related]
14. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
[TBL] [Abstract][Full Text] [Related]
15. Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma.
Ding YF; Lin YW; Chiu WK; Lin CW; Yang YC; Chang LC; Chang J; Yang SF; Chien MH
Aging (Albany NY); 2022 May; 14(10):4500-4512. PubMed ID: 35587368
[TBL] [Abstract][Full Text] [Related]
16. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
17. Hypovitaminosis D, oral potentially malignant disorders, and oral squamous cell carcinoma: a systematic review.
Maturana-Ramírez A; Aitken-Saavedra J; Guevara-Benítez AL; Espinoza-Santander I
Med Oral Patol Oral Cir Bucal; 2022 Mar; 27(2):e135-e141. PubMed ID: 35218642
[TBL] [Abstract][Full Text] [Related]
18. Prognostic outcomes of oral squamous cell carcinoma derived from proliferative verrucous leukoplakia: A systematic review.
Faustino ISP; de Pauli Paglioni M; de Almeida Mariz BAL; Normando AGC; Pérez-de-Oliveira ME; Georgaki M; Nikitakis NG; Vargas PA; Santos-Silva AR; Lopes MA
Oral Dis; 2023 May; 29(4):1416-1431. PubMed ID: 35199416
[TBL] [Abstract][Full Text] [Related]
19. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
[TBL] [Abstract][Full Text] [Related]
20. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
Liu H; Zhang H; Fan H; Tang S; Weng J
Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]